行情

INM

INM

Inmed Pharmaceuticals Inc
NASDAQ

实时行情|Nasdaq Last Sale

0.3973
+0.0022
+0.56%
已收盘, 18:26 08/11 EDT
开盘
0.3999
昨收
0.3951
最高
0.3999
最低
0.3800
成交量
7.08万
成交额
--
52周最高
2.590
52周最低
0.3400
市值
646.28万
市盈率(TTM)
-0.3293
分时
5日
1月
3月
1年
5年
暂无数据
暂无数据
了解INM最新的财务预测,通过INM每股收益,每股净资产,每股现金流等数据分析Inmed Pharmaceuticals Inc近期的经营情况,然后做出明智的投资选择。
分析师评级

1位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

0.00%强力推荐
0.00%买入
100.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测INM价格均价为3.400,最高价位6.00,最低价为0.8000。
最高6.00
均价3.400
最低0.8000
现价0.3973
EPS
实际EPS
预期EPS
-0.33-0.25-0.16-0.08
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
机构持股
总机构数: 19
机构持股: 36.13万
持股比例: 2.22%
总股本: 1,626.67万
类型机构数股数
增持
1
1,000
建仓
4
10.77万
减持
3
14.34万
平仓
1
1.11万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
-1.11%
制药与医学研究
-1.16%
高管信息
Non-Executive Chairman/Independent Director
William Garner
President/Chief Executive Officer/Director
Eric Adams
Chief Financial Officer
Brenda Edwards
Chief Operating Officer
Michael Woudenberg
Senior Vice President
Alexandra Mancini
Vice President/Director of Sales/Director of Marketing
Jerry Griffin
Director
Bryan Baldasare
Director
Janet Grove
Director
Nicole Lemerond
Independent Director
Andrew Hull
暂无数据
暂无数据
INM 简况
InMed Pharmaceuticals Inc. is a clinical stage pharmaceutical company that is engaged in the development, manufacturing and commercialization of rare cannabinoids. The Company is developing a pipeline of prescription-based products targeting treatments for diseases with unmet medical needs as well as developing manufacturing technologies. It is specializing in the research and development of cannabinoid-based therapies and a system for the manufacturing of pharmaceutical-grade cannabinoids. It is also developing an integrated biosynthesis-based manufacturing approach, called IntegraSyn, for synthesizing pharmaceutical-grade cannabinoids, for potential use in product candidates. The Company's two product candidates include INM-755 and INM-088. INM-755 is developed as a topical skin cream formulation containing cannabinol (CBN) for the treatment of symptoms related to Epidermolysis Bullosa (EB). INM-088 provides direct neuroprotection and reduce intraocular pressure in the eye.

微牛提供InMed Pharmaceuticals Inc(NASDAQ-INM)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的INM股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易INM股票基本功能。